Table 1.

Baseline characteristics by randomized group

Characteristic	Control (n=90)	Exercise (n=87)	Diet (n=87)	Exercise & Diet (n=87)
Age, y	59.0 (8.5)	59.1 (8.1)	59.4 (9.2)	60.0 (9.0)
Race, n (%)
White	66 (73.3%)	50 (57.5%)	52 (59.8%)	50 (57.5%)
Black	22 (24.4%)	36 (41.4%)	32 (36.8%)	32 (36.8%)
Other	2 (2.2%)	1 (1.1%)	3 (3.3%)	5 (5.8%)
Education, n (%)
High school or less	19 (21.1%)	15 (17.2%)	12 (13.8%)	18 (20.7%)
Some college	28 (31.1%)	29 (33.3%)	36 (41.4%)	29 (33.3%)
College degree or more	43 (47.8%)	43 (49.4%)	39 (44.9%)	40 (46.0%)
Time since cancer diagnosis, mo.	97.5 (61.3)	92.6 (64.3)	89.9 (66.9)	87.8 (61.7)
Cancer stage, n (%)
Ductal carcinoma in situ	10 (11.1%)	6 (6.9%)	5 (5.8%)	3 (3.4%)
I	19 (21.1%)	24 (27.6%)	17 (19.5%)	14 (16.0%)
II	23 (25.6%)	24 (27.6%)	29 (33.3%)	28 (32.2%)
III	16 (17.8%)	13 (14.9%)	20 (23.0%)	21 (24.1%)
Unknown	22 (24.4%)	20 (23.0%)	16 (18.4%)	21 (24.1%)
No. of nodes removed, n	12.7 (9.5)	12.6 (9.4)	12.5 (9.8)	12.0 (8.3)
Cancer treatments, n (%)
Chemotherapy	74 (82.2%)	65 (74.7%)	71 (81.6%)	79 (90.8%)
Radiotherapy	73 (81.1%)	73 (83.9%)	69 (79.3%)	73 (83.9%)
Tamoxifen	10 (11.1%)	10 (11.5%)	10 (11.5%)	6 (6.9%)
Aromatase inhibitor	31 (34.4%)	25 (28.7%)	22 (25.3%)	24 (27.6%)
Arm volume difference, %	9.6 (14.4)	8.8 (16.6)	8.7 (13.5)	7.6 (13.7)
Body mass index, kg/m2	34.0 (5.7)	34.0 (5.7)	33.8 (5.6)	34.2 (6.3)
Self-rated general health, n (%)
Excellent	4 (4.4%)	1 (1.1%)	4 (4.6%)	1 (1.1%)
Very good	22 (24.4%)	25 (28.7%)	21 (24.1%)	20 (23.0%)
Good	48 (53.3%)	43 (49.4%)	44 (50.6%)	47 (54.0%)
Fair	15 (16.7%)	18 (20.7%)	17 (19.5%)	18 (20.7%)
Poor	1 (1.1%)	0 (0.0%)	1 (1.1%)	1 (1.1%)

Values are mean ± standard deviation or n (%). Percentages may not sum to 100.0% due to rounding error.